A detailed history of Carnegie Capital Asset Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Carnegie Capital Asset Management, LLC holds 11,869 shares of NVS stock, worth $1.31 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
11,869
Previous 11,037 7.54%
Holding current value
$1.31 Million
Previous $1.17 Million 16.27%
% of portfolio
0.04%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$106.13 - $120.89 $88,300 - $100,580
832 Added 7.54%
11,869 $1.37 Million
Q2 2024

Jul 19, 2024

BUY
$92.57 - $107.37 $185 - $214
2 Added 0.02%
11,037 $1.17 Million
Q1 2024

May 03, 2024

SELL
$95.27 - $108.47 $50,969 - $58,031
-535 Reduced 4.62%
11,035 $1.07 Million
Q4 2023

Jan 29, 2024

SELL
$92.27 - $101.54 $4,798 - $5,280
-52 Reduced 0.45%
11,570 $1.17 Million
Q3 2023

Oct 10, 2023

SELL
$94.73 - $105.13 $30,787 - $34,167
-325 Reduced 2.72%
11,622 $1.18 Million
Q2 2023

Aug 04, 2023

SELL
$92.52 - $104.91 $2,590 - $2,937
-28 Reduced 0.23%
11,947 $1.21 Million
Q1 2023

Apr 19, 2023

SELL
$80.03 - $92.81 $40,015 - $46,405
-500 Reduced 4.01%
11,975 $1.1 Million
Q4 2022

Jan 23, 2023

SELL
$75.55 - $92.52 $3,475 - $4,255
-46 Reduced 0.37%
12,475 $0
Q3 2022

Oct 13, 2022

BUY
$74.61 - $87.26 $29,172 - $34,118
391 Added 3.22%
12,521 $952,000
Q2 2022

Aug 02, 2022

BUY
$80.52 - $93.75 $81,647 - $95,062
1,014 Added 9.12%
12,130 $1.03 Million
Q2 2022

Jul 13, 2022

SELL
$80.52 - $93.75 $62,725 - $73,031
-779 Reduced 6.55%
11,116 $1.01 Million
Q1 2022

Apr 11, 2022

SELL
$80.11 - $90.62 $1,682 - $1,903
-21 Reduced 0.18%
11,895 $1.04 Million
Q4 2021

Jan 21, 2022

BUY
$79.7 - $88.13 $63,760 - $70,504
800 Added 7.2%
11,916 $1.04 Million
Q2 2021

Jul 16, 2021

BUY
$85.24 - $94.15 $21,480 - $23,725
252 Added 2.32%
11,116 $1.01 Million
Q1 2021

Apr 12, 2021

SELL
$83.5 - $98.47 $25,050 - $29,541
-300 Reduced 2.69%
10,864 $929,000
Q4 2020

Feb 08, 2021

SELL
$78.07 - $94.43 $55,039 - $66,573
-705 Reduced 5.94%
11,164 $1.05 Million
Q3 2020

Oct 13, 2020

SELL
$82.14 - $91.0 $1,642 - $1,820
-20 Reduced 0.17%
11,869 $1.03 Million
Q1 2020

May 08, 2020

SELL
$70.67 - $99.01 $2,473 - $3,465
-35 Reduced 0.29%
11,889 $979,000
Q3 2019

Nov 20, 2019

SELL
$85.54 - $94.26 $36,354 - $40,060
-425 Reduced 3.44%
11,924 $1.04 Million
Q2 2019

Jul 24, 2019

SELL
$75.4 - $92.8 $16,361 - $20,137
-217 Reduced 1.73%
12,349 $1.13 Million
Q1 2019

May 14, 2019

SELL
$75.32 - $86.15 $45,191 - $51,690
-600 Reduced 4.56%
12,566 $1.21 Million
Q4 2018

Feb 14, 2019

SELL
$73.66 - $82.02 $133,029 - $148,128
-1,806 Reduced 12.06%
13,166 $1.13 Million
Q3 2018

Nov 27, 2018

BUY
$66.94 - $77.43 $135,285 - $156,486
2,021 Added 15.6%
14,972 $1.31 Million
Q2 2018

Aug 16, 2018

SELL
$64.91 - $73.36 $38,816 - $43,869
-598 Reduced 4.41%
12,951 $1.06 Million
Q1 2018

May 15, 2018

SELL
$70.39 - $84.15 $8,728 - $10,434
-124 Reduced 0.91%
13,549 $1.05 Million
Q4 2017

Feb 12, 2018

BUY
$72.33 - $77.64 $187,334 - $201,087
2,590 Added 23.37%
13,673 $1.16 Million
Q3 2017

Nov 14, 2017

SELL
$74.14 - $77.27 $9,786 - $10,199
-132 Reduced 1.18%
11,083 $952,000
Q2 2017

Aug 14, 2017

BUY
N/A
11,215
11,215 $956,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Carnegie Capital Asset Management, LLC Portfolio

Follow Carnegie Capital Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carnegie Capital Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carnegie Capital Asset Management, LLC with notifications on news.